Patents by Inventor Navneet Puri

Navneet Puri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240342154
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Application
    Filed: June 26, 2024
    Publication date: October 17, 2024
    Applicant: Vyluma Inc.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan Ali Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Patent number: 12036217
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: June 28, 2023
    Date of Patent: July 16, 2024
    Assignee: VYLUMA INC.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan Ali Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Publication number: 20230355604
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Application
    Filed: June 28, 2023
    Publication date: November 9, 2023
    Applicant: Vyluma Inc.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan Ali Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Publication number: 20230106270
    Abstract: Compositions and methods for an injectable liquid formulation for reducing consumption or need of a postoperative analgesic compound by a patient are presented. The pharmaceutical formulation can contain a non-opioid analgesic and a gabapentinoid, and can be administered prior to surgery to reduce postoperative pain.
    Type: Application
    Filed: December 6, 2022
    Publication date: April 6, 2023
    Applicant: Nevakar Injectables Inc.
    Inventors: Varun Khurana, Jack Martin Lipman, Milan Patel, Iouri V. Ilitchev, Tushar Hingorani, Kumaresh Soppimath, Navneet Puri
  • Patent number: 11547686
    Abstract: Compositions and methods for an injectable liquid formulation for reducing consumption or need of a postoperative analgesic compound by a patient are presented. The pharmaceutical formulation can contain a non-opioid analgesic and a gabapentinoid, and can be administered prior to surgery to reduce postoperative pain.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: January 10, 2023
    Assignee: NEVAKAR INJECTABLES INC.
    Inventors: Varun Khurana, Jack Martin Lipman, Milan Patel, Iouri Ilitchev, Tushar Hingorani, Kumaresh Soppimath, Navneet Puri
  • Patent number: 11464769
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: October 11, 2022
    Assignee: VYLUMA INC.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Patent number: 11071732
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: July 27, 2021
    Assignee: NEVAKAR INC.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Publication number: 20210169897
    Abstract: Compositions and methods for injectable and liquid fulvestrant formulations that have fulvestrant at a relatively high concentration stably solubilized before and after injection of the patient are provided.
    Type: Application
    Filed: December 6, 2018
    Publication date: June 10, 2021
    Inventors: Vivek Yadav, Sriramya Garapati, Bronislava Zektser, Varun Khurana, Iouri V Ilitchev, Prem Sagar Akasapu, Tushar Hingorani, Kumaresh Soppimath, Navneet Puri
  • Publication number: 20210128507
    Abstract: Formulations, methods of manufacturing, methods of stabilizing, kits, and uses as medicament are provided, for example for the treatment of pain. The formulations can comprise gabapentin optionally combined with at least one non-opioid pain drug in an aqueous carrier. The pharmaceutical formulation can have a pH of about 2.0 to about 10.0. The at least one non-opioid pain drug can be acetaminophen. The components can be included in any amount suitable for purposes of obtaining properties desirable for an injectable infusion, for example an intravenous infusion.
    Type: Application
    Filed: November 16, 2020
    Publication date: May 6, 2021
    Inventors: Varun Khurana, Vivek Yadav, Jack Martin Lipman, Tao Zhang, Iouri V. Ilitchev, Tushar Hingorani, Kumaresh Soppimath, Navneet Puri
  • Patent number: 10874626
    Abstract: Formulations, methods of manufacturing, methods of stabilizing, kits, and uses as medicament are provided, for example for the treatment of pain. The formulations can comprise gabapentin optionally combined with at least one non-opioid pain drug in an aqueous carrier. The pharmaceutical formulation can have a pH of about 2.0 to about 10.0. The at least one non-opioid pain drug can be acetaminophen. The components can be included in any amount suitable for purposes of obtaining properties desirable for an injectable infusion, for example an intravenous infusion.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: December 29, 2020
    Assignee: Nevakar Inc.
    Inventors: Varun Khurana, Vivek Yadav, Jack Martin Lipman, Tao Zhang, Iouri V. Ilitchev, Tushar Hingorani, Kumaresh Soppimath, Navneet Puri
  • Publication number: 20200352928
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Application
    Filed: July 20, 2020
    Publication date: November 12, 2020
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Publication number: 20200230091
    Abstract: Compositions and methods for an injectable liquid formulation for reducing consumption or need of a postoperative analgesic compound by a patient are presented. The pharmaceutical formulation can contain a non-opioid analgesic and a gabapentinoid, and can be administered prior to surgery to reduce postoperative pain.
    Type: Application
    Filed: October 2, 2018
    Publication date: July 23, 2020
    Applicant: Nevakar Inc.
    Inventors: Varun KHURANA, Jack Martin LIPMAN, Milan PATEL, Iouri ILITCHEV, Tushar HINGORANI, Kumaresh SOPPIMATH, Navneet PURI
  • Patent number: 10610525
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: April 7, 2020
    Assignee: Nevakar Inc.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Patent number: 10583132
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: March 10, 2020
    Assignee: Nevakar Inc.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Patent number: 10576074
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: March 3, 2020
    Assignee: Nevakar Inc.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Patent number: 10568875
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: February 25, 2020
    Assignee: Nevakar Inc.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Publication number: 20190209545
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Application
    Filed: February 20, 2019
    Publication date: July 11, 2019
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Publication number: 20190192499
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Application
    Filed: February 20, 2019
    Publication date: June 27, 2019
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Publication number: 20190183876
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Application
    Filed: February 20, 2019
    Publication date: June 20, 2019
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Patent number: RE50040
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: July 16, 2024
    Assignee: VYLUMA INC.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev